Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionDfa Investment Trust Co - The Japanese Small Company Series
Latest Disclosed Ownership154,818 shares
Latest Disclosed Value $ 1,241,315
Dfa Investment Trust Co - The Japanese Small Company Series reports 4.74% increase in ownership of 4577 / Daito Pharmaceutical Co.,Ltd.

On June 24, 2026 - Dfa Investment Trust Co - The Japanese Small Company Series filed a NPORT-P form disclosing ownership of 154,818 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $195,225,498 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 147,818 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 4.74% during the quarter. The current value of the position is $209,933,208 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-24 2026-04-30 NP Daito Pharmaceutical Co. EC JP3486150000 154,818 7,000 4.74 1,241 -2.74 0.0332
2026-03-27 2026-01-31 NP Daito Pharmaceutical Co. EC JP3486150000 147,818 0 0.00 1,276 7.05 0.0356
2025-12-22 2025-10-31 NP Daito Pharmaceutical Co. EC JP3486150000 147,818 0 0.00 1,192 0.93 0.0358
2025-09-25 2025-07-31 NP Daito Pharmaceutical Co. EC JP3486150000 147,818 73,909 100.00 1,181 9.66 0.0378
2025-06-26 2025-04-30 NP Daito Pharmaceutical Co. EC JP3486150000 73,909 -2,400 -3.15 1,077 5.69 0.0355
2025-03-26 2025-01-31 NP Daito Pharmaceutical Co. EC JP3486150000 76,309 1,000 1.33 1,019 -7.36 0.0355
2024-12-23 2024-10-31 NP Daito Pharmaceutical Co. EC JP3486150000 75,309 -6,029 -7.41 1,100 -15.32 0.0370
2024-09-26 2024-07-31 NP Daito Pharmaceutical Co. EC JP3486150000 81,338 0 0.00 1,299 0.08 0.0402
2024-06-25 2024-04-30 NP Daito Pharmaceutical Co. EC JP3486150000 81,338 0 0.00 1,299 19.63 0.0431
2024-03-28 2024-01-31 NP Daito Pharmaceutical Co. EC JP3486150000 81,338 0 0.00 1,086 4.43 0.0362
2023-12-20 2023-10-31 NP Daito Pharmaceutical Co. EC JP3486150000 81,338 3,758 4.84 1,039 -18.64 0.0368
2023-09-29 2023-07-31 NP Daito Pharmaceutical Co. EC JP3486150000 77,580 0 0.00 1,277 -11.50 0.0426
2023-06-23 2023-04-30 NP Daito Pharmaceutical Co. EC JP3486150000 77,580 0 0.00 1,444 -8.09 0.0502
2023-03-27 2023-01-31 NP Daito Pharmaceutical Co. EC JP3486150000 77,580 0 0.00 1,571 17.69 0.0540
2022-12-28 2022-10-31 NP Daito Pharmaceutical Co. EC JP3486150000 77,580 -1,000 -1.27 1,334 -14.49 0.0529
2022-09-28 2022-07-31 NP Daito Pharmaceutical Co. EC JP3486150000 78,580 0 0.00 1,561 -0.70 0.0562
2022-06-28 2022-04-30 NP Daito Pharmaceutical Co. EC JP3486150000 78,580 0 0.00 1,572 -17.58 0.0575
2022-03-29 2022-01-31 NP Daito Pharmaceutical EC JP3486150000 78,580 0 0.00 1,906 -13.95 0.0609
2021-12-09 2021-10-31 NP Daito Pharmaceutical EC JP3486150000 78,580 1,200 1.55 2,216 -5.66 0.0649
2021-09-24 2021-07-31 NP Daito Pharmaceutical EC JP3486150000 77,380 0 0.00 2,349 -4.36 0.0748
2021-06-15 2021-04-30 NP Daito Pharmaceutical EC JP3486150000 77,380 0 0.00 2,455 -10.30 0.0795
2021-03-25 2021-01-31 NP Daito Pharmaceutical EC JP3486150000 77,380 0 0.00 2,737 -7.41 0.0894
2020-12-17 2020-10-31 NP Daito Pharmaceutical EC JP3486150000 77,380 0 0.00 2,956 28.80 0.1004
2020-09-29 2020-07-31 NP Daito Pharmaceutical EC JP3486150000 77,380 -1,000 -1.28 2,295 -13.00 0.0795
2020-06-18 2020-04-30 NP Daito Pharmaceutical EC JP3486150000 78,380 -7,400 -8.63 2,638 -4.45 0.0878
2020-03-31 2020-01-31 NP Daito Pharmaceutical EC JP3486150000 85,780 -1,800 -2.06 2,762 4.70 0.0770
2019-12-20 2019-10-31 NP Daito Pharmaceutical EC JP3486150000 87,580 87,580 2,637 0.0704
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.